力大圖書
力 大 醫 學 圖 書 網          www.leaderbook.com.tw          歡迎使用  國民旅遊卡!!
帳號 密碼
加入會員 | 首頁 | 服務 | 行銷回應 | 代訂 | 購物車 | 預訂清單
Search
      圖書搜尋

 - 進階搜尋
  代訂書籍
  加購書籍專區
Classes
      圖書類別
運費(購買金額未滿NT$1000,請自行加上運費)
文化幣使用須知
台灣Pay使用須知
全支付使用須知
國民旅遊卡使用須知
購買注意事項與營業時間
力大圖書出版品
橘井文化系列叢書
免疫風濕科
內分泌科
內科(家醫科及實証醫學)
婦產科
眼科
病理科(檢驗科)
外科
耳鼻喉科(聽力和語言治療)
泌尿科
胸腔內科(重症醫學)
胸腔外科
腫瘤科(血液科)
放射腫瘤科
麻醉科(疼痛科)
獸醫科
神經外科
神經內科
小兒科
心臟內科
心臟血管外科
急診科
感染科
放射線科
核子醫科
牙科(口腔外科)
皮膚科(醫學美容)
精神科
胃腸科
骨科
腎臟科
整形外科
藥劑科
復健科(運動醫學)
護理科
食品營養
限量特價專區
解剖學(組織學)
基礎醫學科
醫學模型
醫學掛圖
SPRINGER庫存出清專區
 
 
 
-■ ■ ■ ■ ■ ■ 圖 書 介 紹
Atlas of Psychiatric Pharmacotherapy 2/e
-精神科
- 編號: 0-0000018418428189
- 作者:Roni Shiloh
- 原價-4730    - (熱賣價)3870      - 節省 ↓18%
- 加入購物車
推薦指數:
- 內容介紹
Atlas of Psychiatric Pharmacotherapy
Roni Shiloh, Rafael Stryjer, David J. Nutt, Abraham Weizman
Publisher: Taylor & Francis
ISBN: 1841842818
Pub Date:2006 2/e
Type: Hardback Book
Extent: 240 pages
Illustrations: 200

Building upon the success of the previous edition, this new text provides a comprehensive understanding of the mechanisms of action involved in psychiatric pharmacotherapy.

Using imaginative and colorful double-page spreads, this exceptional book presents state-of-the-art information on all the basic principles of psychiatric pharmacotherapy, abused substances, drug interactions, and treatment strategies.
Contents:
Introduction
1. Basic Principles of Psychiatric Pharmacotherapy
1.1 Principles of drug action ?presynaptic nerve
Main reactions relevant for psychiatric pharmacotherapy
1.2 Principles of drug action ?postsynaptic nerve
Main reactions relevant for psychiatric pharmacotherapy
1.3 Signal transduction (I)
G-protein complex and activation of second messengers
1.4 Signal transduction (II)
Activation of protein kinase and subsequent protein phosphorilation
1.5 Signal transduction (III)
Gene expression
1.6 Neurotransmitters (I)
Monoamines ?synthesis and degradation
1.7 Neurotransmitters (II)
Glutamate (excitatory) ?synthesis and degradation
1.8 Neurotransmitters (III)
gamma-aminobutyric acid (GABA; inhibitory) ?
synthesis and degradation
1.9 Vesicular monoamine transporter type 2 (VMAT-2)
Mode of action
1.10 Intracellular modifications following activation of various receptors (I)
Changes in intracellular compounds following activation of major receptors
1.11 Receptor-mediated psychiatric symptoms/syndromes
Assumed role of specific receptors in major psychiatric syndromes
1.12 Receptor/transporter-mediated `non-psychiatric?symptoms
Assumed role of specific receptors in protecting from-/inducing `non-psychiatric?symptoms
1.13 Drugs?pharmacokinetics
Main pathways of drug metabolism
1.14 Drug?pharmacokinetics
Major CYP450 enzymes responsible for metabolizing various `non-psychiatric?drugs
1.15 Drugs pharmacokinetics
Major `psychiatric drugs affecting the hepatic CYP450 enzymes

2. Antidepressants and mood stabilizers
2.1 Major depressive disorder - Depressive state ?no treatment
2.2 Antidepressant drugs
Schematic classification according to main mode of therapeutic action
2.3 Major depressive disorder - Cellular changes following antidepressant treatment
2.4 Antidepressant drugs
Recently developed antidepressants ?SNRIs
Recently developed antidepressants ?mirtazapine

Recently developed antidepressants ?escitalopram
2.5 Pindolol ?5HT1A- and beta-adrenergic antagonist
Supposed mode of accelerating and augmenting the antidepressant effect of SSRIs
2.6 Antidepressant drugs - Comparative affinities to various receptors/transporters
2.7 Antidepressant drugs - The main CYP450 hepatic enzymes responsible for metabolizing antidepressant drugs
2.8 Antidepressant drugs - Main adverse side effects (I) ?anticholinergic and central nervous system (CNS) effects
2.9 Antidepressant drugs - Main adverse side effects (II) ?gastrointestinal and cardiovascular effects
2.10 Antidepressant drugs - Comparative sexual side-effect profile
2.11 Antidepressant drugs - Effects of antidepressant drugs on various sleep parameters
2.12 Antidepressant drugs - Monoamine oxidase inhibitors
2.13 Antidepressant drugs - Potential future developments
2.14 Antimanic treatments - Supposed mechanism of action
2.15 Mood stabilizers - Lithium
2.16 Mood stabilizers - Carbamazepine
2.17 Mood stabilizers - Valproate
2.18 Mood stabilizers - Topiramate
2.19 Mood stabilizers - Lamotrigine
2.20 Mood stabilizers - Comparative profile
3. Anxiolytic drugs
3.1 Anxiolytics (I) - The `fear?network and the role of serotonin in suppressing anxiety
3.2 Anxiolytics (II) - Mechanism of anxiolytic action of various drugs
3.3 Anxiolytics (III) - New approache




歡迎使用國民旅遊卡
歡迎使用國民旅遊卡
其他相關書藉
  請輸入關鍵字
相 關 書 藉
Kaplan and Sadocks Comprehensive Textbook of Psychiatry 11/E 2025
- 精神科
- 作者:Robert Boland
Adolescent Psychiatry, An Issue of Adolescent Medicine Clinics
- 精神科
- 作者:Richard E. Kreipe, MD
Clinical Geriatric Psychopharmacology Hardbound
- 精神科
- 作者:Carl Salzman MD
Clinical Manual for Treatment of Schizophrenia 2012
- 精神科
- 作者: John Lauriello, M.D
Oxford Textbook of Suicidology and Suicide Prevention 2009
- 精神科
- 作者:Danuta, Wasserman, M.D.
--- more
[ 積點系統 ]
您已經累積多少點數您知道嗎?別忘了登錄會員,察看您的點數,獎品就等您來拿喲!
[ 訂購辦法 ]
您還不知道要在本網站如何購物嗎?我們將會提供給您訂購的方法及購物相關資訊喲!讓您彈指間取得想要的書藉。
 
      圖書搜尋         本網站購物機制使用 SSL+ 加密技術,請放心購物 Safe100%

| 加入會員 | 回首頁 | 服務中心 | 行銷回應 | 購物須知 | 會員條款 | 關於力大 | 權益申明 | 合作對象 |

本站內容為 力大圖書有限公司 所有,未經同意,請勿任意引用轉載
電話:(02)2733-2592 傳真:(02)2732-5743 E-mail:service@leaderbook.com.tw
力大圖書:台北市和平東路二段90巷2號4樓之2
Copyright 2002-2024 LeaderBook CO.,LTD All rights reserved.